Market, Research, Report, Business, Industry, Information, Automotive, Banking, Finance, Food, Beverages, Technology, Biomass, Books, Conference, Company Profiles, Country

 
  Aarkstore.com - Business Market Research Reports Aggregator
  
   
Your Comprehensive Resource
 For Market Research

   
   
 Home  Contact us  Login
  Web Search :

 
   

Global Stem Cell and Advanced Technologies Market

Published Date :  November 2009
Pages : 229
  Add to Cart - Global Stem Cell and Advanced Technologies Market
 

Report Description

The stem cell market is growing rapidly due to increasing regulatory approval and public acceptance bodies. The benefits of stem cell therapy are attracting an increasing number of patients. The product submarket for human and embryo stem cells are expected to drive the growth of the overall market. In addition, intensive R&D efforts and the increasing investments into research on stem cells therapy are soon expected to improve the efficacy of stem cell treatment. However, the high cost of the therapy may affect market growth.

The global stem cell market is estimated to be $88.3 billion by 2014, growing at a CAGR of 14.8 % from 2009 to 2014. The U.S. currently holds a 60% share of the global stem cell market; and forms an especially lucrative market for areas such as bone marrow transplantation through stem cells. This research report will help stakeholders gain a better understanding of product pricing and regulatory framework governing the dynamics of the stem cell market. The key players in the market include Osiris Therapeutics, Stem Tronix Inc., Stemcell Technologies, Genzyme Corp., Cytori, and Geron.

Market Estimates and Forecasts

The report categorizes the global stem cell market as follows:
• Stem Cell Products (adult stem cell, human embryonic stem cell, and other stem cell types)
• Stem Cell Services (stem cell banking, stem cell acquisition and testing, drug discovery and target identification, isolation/characterization services, and molecular biology )
• Stem Cell Technologies (stem cell acquisition, stem cell production, cryopreservation, and expansion and subculture)
• Stem Cell Applications (regenerative medicine – neurological disorders, orthopedics, cancer, hematological disorders, myocardial infarction and cardiovascular diseases, injuries, diabetes, liver disorder, incontinence, and drug development)

Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide market tables for various geographic regions covering the sub-segments and micro-markets. In addition, the report also provides more than 35 company profiles for each of its sub-segments.

What makes our reports unique?

- We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.
- We provide 10% customization. Normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
- We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.
- Comprehensive market analysis for the following sectors:
Pharmaceuticals, Medical Devices, Biotechnology, Semiconductor and Electronics, Energy and Power Supplies, Food and Beverages, Chemicals, Advanced Materials, Industrial Automation, and Telecom and IT. We also analyze retailers and super-retailers, technology providers, and research and development (R&D) companies.

Key questions answered

- Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, and stakeholders?
- What are market estimates and forecasts; which markets are doing well and which are not?
- Where are the gaps and opportunities; what is driving the market?
- Which are the key playing fields? Which are the winning edge imperatives?
- How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and analysis

The analysts come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.
 

 

Table of Contents :


 

1. INTRODUCTION
1.1. KEY TAKE AWAYS
1.2. MARKETS COVERED
1.3. STAKEHOLDERS
1.3.1. MINIMALLY/NON-INVASIVE SURGICAL EQUIPMENT MANUFACTURING COMPANIES
1.3.2. HOSPITAL SURGICAL DEPARTMENTS AND INDIVIDUAL SURGEONS
1.3.3. OUTPATIENT SURGERY CENTERS
1.3.4. BUSINESS RESEARCH AND CONSULTING SERVICE PROVIDERS
2. SUMMARY
3. MARKET OVERVIEW
3.1. EVOLUTION OF THE MINIMALLY INVASIVE SURGERY MARKET
3.1.1. MINIMALLY INVASIVE SURGERY VS CONVENTIONAL OPEN SURGERY
3.2. THE FUTURE OF MINIMALLY INVASIVE SURGERY
3.3. DEFINING THE MINIMALLY INVASIVE SURGERY MARKET
3.4. DEFINING THE MINIMALLY INVASIVE PRODUCT MARKET
3.5. DEFINING THE MINIMALLY INVASIVE APPLICATION MARKET
3.6. DEFINING THE MINIMALLY INVASIVE TECHNOLOGY MARKET
3.7. DEFINING THE MINIMALLY INVASIVE END-USER MARKET
3.8. MARKET DRIVERS FOR MINIMALLY INVASIVE SURGERY MARKET
3.8.1. INCREASE IN AGING POPULATION BOOSTS THE DEMAND FOR SURGERIES
3.8.2. INCREASE IN AWARENESS AND DEMAND FOR PATIENT-FRIENDLY OPERATING METHODS
3.8.3. MINIMALLY INVASIVE SURGERY HELPS REDUCE HEALTHCARE COST
3.9. RESTRAINTS FOR THE MINIMALLY INVASIVE SURGERY MARKET
3.10.OPPORTUNITIES IN THE MINIMALLY INVASIVE SURGERY MARKET
3.10.1. HUGE MARKET SIZE ATTRACTING NEW ENTRANTS IN MINIMALLY INVASIVE MARKET
3.10.2. PHYSICIANS ARE SETTING A STRONG FOUNDATION FOR THE FUTURE OF MINIMALLY INVASIVE SURGERY MARKET
4. MINIMALLY INVASIVE PRODUCT MARKET
4.1. SURGICAL DEVICES
4.1.1. MARKET DRIVERS
4.1.1.1. INNOVATIVE MARKETING MODEL BOOSTING THE DEMAND FOR MIS INSTRUMENTS
4.1.1.2. INCREASING NUMBER OF MIS PROCEDURES IS BOOSTING THE DEMAND FOR MIS INSTRUMENTS
4.1.2. HAND INSTRUMENTS
4.1.3. FORCEPS/GRASPERS/DISSECTORS
4.1.4. SCISSORS
4.1.5. INSUFFLATORS
4.1.5.1. DEVELOPMENTS
4.1.6. POWER SURGICAL INSTRUMENTS
4.1.7. OTHER SURGICAL DEVICES
4.2. MONITORING AND VISUALIZATION SYSTEMS
4.2.1. MARKET DRIVERS
4.2.2. CAMERAS AND VIDEO SUPPORT
4.2.3. OTHER MONITORING AND VISUALIZATION MARKET
4.3. ELECTROSURGICAL AND AUXILIARY EQUIPMENT
4.3.1. LASERS
4.3.1.1. DRIVERS
4.3.2. OTHER MARKET
4.4. ENDOSURGICAL EQUIPMENT
4.4.1. MARKET DRIVERS
4.4.2. ENDOSCOPES AND OTHER ENDOSURGICAL EQUIPMENT
4.5. MEDICAL ROBOTICS
4.5.1. MARKET DRIVERS
4.5.1.1. IMPROVED SURGICAL RESULTS ATTRACTING MORE PATIENTS
4.5.1.2. MEDICAL ROBOTICS INCREASE HOSPITAL REVENUE
4.5.2. SURGICAL NAVIGATION SYSTEMS
4.5.3. SURGICAL ROBOTS
4.5.3.1. DRIVERS
4.5.4. DIGITAL OPERATING ROOMS
4.5.5. OTHERS
5. MINIMALLY INVASIVE SURGERY MARKET BY APPLICATION
5.1. COSMETIC SURGERY
5.1.1. DRIVERS
5.1.2. PLASTIC SURGERY
5.1.3. BREAST SURGERY
5.1.4. OBESITY SURGERY
5.1.4.1. DRIVERS
5.1.4.1.1. INCREASING INCIDENCE OF OBESITY IS DRIVING THE BARIATRIC SURGERY MARKET
5.1.4.1.2. INCREASE IN AWARENESS OF OBESITY AS A DANGEROUS DISEASE
5.1.5. HAIR REMOVAL
5.1.5.1. DRIVERS AND RESTRAINTS
5.2. GASTROINTESTINAL SURGERY
5.2.1. MARKET DRIVERS
5.3. GYNECOLOGICAL SURGERY
5.3.1. HYSTERECTOMIES
5.4. UROLOGICAL SURGERY
5.5. THORACIC SURGERY
5.6. CARDIAC SURGERY
5.6.1. DRIVERS
5.6.1.1. TECHNOLOGY DEVELOPMENTS ARE BOOSTING THE CARDIAC SURGERY MARKET
5.6.1.2. NEW AND IMPROVED SURGICAL PROCEDURES DRIVING THE MARKET GROWTH FOR CARDIAC SURGERY
5.6.2. ROBOT-ASSISTED CARDIAC SURGERY
5.7. VASCULAR SURGERY
5.8. ORTHOPEDIC SURGERY
5.8.1. JOINT REPLACEMENT
5.8.2. SPINAL SURGERY
5.8.3. OTHER SURGERIES
6. MINIMALLY INVASIVE SURGERY MARKET-BY TECHNOLOGY
6.1. NON-VISUAL IMAGING
6.1.1. OPTICAL IMAGING
6.1.1.1. Market Drivers
6.1.2. NON-OPTICAL IMAGING
6.1.3. HYBRID IMAGING
6.2. MEDICAL ROBOTICS
6.2.1. MARKET DRIVERS
6.2.1.1. Improved Surgical Results Attracting Patients
6.2.1.2. Cost effectiveness Attracting Medical Facilities
6.3. TRANSCATHETER SURGERY
6.3.1. PERCUTANEOUS ABLATION
6.3.2. RADIOFREQUENCY ABLATION
6.3.2.1. Market Drivers
6.3.2.1.1. Increasing Consumer Base Driving the Market Growth for RFA
6.3.2.1.2. RFA Gives More Effective Results for Treatment of Liver Tumor
6.3.2.1.3. Most Promising Nonsurgical Ablation for Breast Cancer Treatment
6.3.2.2. Restraints
6.3.2.3. Developments
6.3.3. MICROWAVE ABLATION
6.3.3.1. Market Drivers
6.3.3.1.1. Microwave Ablation Takes Lesser Time for Operating Tumors
6.3.3.1.2. Microwave Ablation Involves Faster Generation of Heat
6.4. LAPAROSCOPIC SURGERY
7. MINIMALLY INVASIVE SURGERY MARKET BY END-USERS
7.1. HOSPITAL SURGICAL DEPARTMENTS
7.1.1. MARKET DRIVERS
7.2. OUTPATIENTS SURGERY CENTER
7.2.1. MARKET DRIVERS
7.3. GROUP PRACTICES
7.4. INDIVIDUAL SURGEONS
7.5. MEDICAL SCHOOLS
7.6. OTHER USERS
8. MINIMALLY INVASIVE SURGERY PATENT ANALYSIS
9. MINIMALLY INVASIVE SURGERY MARKET COMPANY PROFILES
9.1. ABBOTT LABORATORIES
9.1.1. OVERVIEW
9.1.2. STRATEGIES AND DEVELOPMENTS
9.2. AESCULAP (A SUBSIDIARY OF B. BRAUN)
9.2.1. OVERVIEW
9.2.2. STRATEGIES AND DEVELOPMENTS
9.3. ARTHROCARE CORP.
9.3.1. OVERVIEW
9.3.2. STRATEGY AND DEVELOPMENTS
9.4. BIOMET, INC.
9.4.1. OVERVIEW
9.4.2. DEVELOPMENTS
9.5. DEPUY SPINE
9.5.1. OVERVIEW
9.5.2. STRATEGIES AND DEVELOPMENTS
9.6. DISC-O-TECH MEDICAL TECHNOLOGIES LTD
9.6.1. OVERVIEW
9.7. ALPHATEC SPINE
9.7.1. OVERVIEW
9.7.2. STRATEGIES AND DEVELOPMENTS
9.8. GIVEN IMAGING
9.8.1. OVERVIEW
9.8.2. STRATEGIES AND DEVELOPMENTS
9.9. HANSEN MEDICAL
9.9.1. OVERVIEW
9.9.2. STRATEGIES AND DEVELOPMENTS
9.10.INTEGRA LIFESCIENCES
9.10.1.OVERVIEW
9.10.2.STRATEGIES AND DEVELOPMENTS
9.11.MENTICE MEDICAL SIMULATION
9.11.1.OVERVIEW
9.11.2.STRATEGY
9.12.NUVASIVE INC.
9.12.1.OVERVIEW
9.12.2.DEVELOPMENTS
9.13.OLYMPUS CORPORATION
9.13.1.OVERVIEW
9.13.2.STRATEGIES AND DEVELOPMENTS
9.14.SMITH & NEPHEW
9.14.1.OVERVIEW
9.14.2.STRATEGIES AND DEVELOPMENTS
9.15.STRYKER CORPORATION
9.15.1.OVERVIEW
9.15.2.STRATEGIES AND DEVELOPMENTS
9.16.SYNTHES, INC.
9.16.1.OVERVIEW
9.16.2.STRATEGY
9.17.TELEFLEX
9.17.1.OVERVIEW
9.17.2.STRATEGIES AND DEVELOPMENTS
9.18.COVIDIEN LTD
9.18.1.OVERVIEW
9.18.2.STRATEGIES AND DEVELOPMENTS
9.19.UNITED STATES SURGICAL CORP. (A SUBSIDIARY OF COVIDIAN)
9.19.1.OVERVIEW
9.20.ZIMMER HOLDINGS INC.
9.20.1.OVERVIEW
9.20.2. STRATEGIES
9.21.MEDTRONIC SOFAMOR DANEK
9.21.1.OVERVIEW
9.21.2.STRATEGIES
9.22.PENTAX MEDICAL COMPANY
9.22.1.OVERVIEW
9.22.2.STRATEGIES AND DEVELOPMENTS
9.23.SURGICAL INNOVATIONS GROUP PLC.
9.23.1.OVERVIEW
9.23.2.DEVELOPMENTS
9.24.K2M INC
9.24.1.OVERVIEW
9.24.2.DEVELOPMENTS
9.25.BOSTON SCIENTIFIC CORPORATION
9.25.1.OVERVIEW
9.25.2.STRATEGIES AND DEVELOPMENTS
9.25.3. DEVELOPMENTS
9.26.CHARLES RUSSELL BARD INC.
9.26.1.OVERVIEW
9.26.2.STRATEGIES AND DEVELOPMENTS
9.27.FUJIFILM CORPORATION
9.27.1.OVERVIEW
9.27.2.STRATEGIES AND DEVELOPMENTS
9.28.KARL STORZ ENDOSKOPE BERLIN GMBH & CO
9.28.1.OVERVIEW
9.28.2.STRATEGY
9.29.GYRUS ACMI CORP.
9.29.1.OVERVIEW
9.30.COOPER SURGICAL INC.
9.30.1.OVERVIEW
9.30.2.STRATEGIES AND DEVELOPMENTS
9.31.CLARUS MEDICAL LLC
9.31.1.OVERVIEW
9.31.2.STRATEGIES
9.32.ETHICON ENDO-SURGERY, INC.
9.32.1.OVERVIEW
9.32.2.STRATEGY
9.33.VALLEYLAB
9.33.1.OVERVIEW
9.33.2.STRATEGIES
9.34.JOHNSON & JOHNSON INC.
9.34.1.OVERVIEW
9.34.2.DEVELOPMENTS
9.35.CONMED CORPORATION
9.35.1.OVERVIEW
9.35.2.DEVELOPMENTS
9.36.INTUITIVE SURGICAL INC
9.36.1.OVERVIEW
APPENDIX
U.S. PATENTS

 
 
Loading
 
 

Privacy Policy | Help/FAQ | Disclaimer | Sitemap | Resources | Research Blog | Feeds |   | 

Copyright © 2010  trademark registered in India. All rights reserved.
Office Phone: (+91) 9272 852585 | Telefax No: (+91) 2224169996
24/7 Online Support: (+91) 8149 852585 | Publishers: (+91) 8080 852585
Office Hours: 9:00 am to 6:00 pm (IST) Monday to Saturday

Email:
contact@aarkstore.com / customersupport@aarkstore.com